Screener
Edwards Lifesciences EW Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 77.8%-1.0pp | 77.9%-1.6pp | 78%-1.4pp | 78.2%-1.6pp | 78.9%-0.7pp | |
| Operating margin | 22.3%-3.6pp | 21.4%-4.4pp | 20.8%-4.5pp | 24.2%-2.3pp | 25.8%-1.6pp | |
| Net margin | 15.4%-57.5pp | 17.4%-58.3pp | 17.7%-59.1pp | 23.2%-54.9pp | 73%+44.7pp | |
| Valuation | ||||||
| Market capitalization | $51.28B+11.2% | $46.17B+8.7% | $49.47B+13.3% | $45.66B+14.9% | $44.49B-20.1% | |
| Price / earnings | 51×+39.9× | 42.1×+32.0× | 46.1×+35.6× | 33.4×+23.8× | 10.7×-27.1× | |
| Price / sales | 7.9×-0.2× | 7.3×-0.4× | 8.2×+0.1× | 7.8×+0.3× | 7.8×-2.9× |
FAQ
- What are Edwards Lifesciences's profit margins?
- Edwards Lifesciences (EW) runs a 77.8% gross margin and a 22.3% operating margin, with a 15.4% net margin.
- Where do Edwards Lifesciences's ratios come from?
- Every ratio is computed from Edwards Lifesciences's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
